Skip to Content

LOXO LARO 25 mg (Vitrakvi 25 mg)

Generic Name: larotrectinib

Pill with imprint LOXO LARO 25 mg is White, Capsule-shape and has been identified as Vitrakvi 25 mg. It is supplied by Loxo Oncology, Inc..

Vitrakvi is used in the treatment of solid tumors and belongs to the drug class multikinase inhibitors. Vitrakvi 25 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for LOXO LARO 25 mg

Vitrakvi

Generic Name
larotrectinib
Imprint
LOXO LARO 25 mg
Strength
25 mg
Color
White
Shape
Capsule-shape
Availability
Prescription only
Drug Class
Multikinase inhibitors
CSA Schedule
Not a controlled drug
Labeler / Supplier
Loxo Oncology, Inc.
National Drug Code (NDC)
71777-0390

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.